In most cancers, represented by esophageal and nonsmall-cell lung cancer, CYGB expression is downregulated through promoter hypermethylation (McRonald et al, 2012; McRonald et al, 2006; Shivapurkar et al, 2008). This evidence concerns the gene CYGB and lung cancer.